BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
June 04, 2024 08:50 ET
|
BioRestorative Therapies, Inc
MELVILLE, NY., June 04, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies,...
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
June 04, 2024 08:42 ET
|
Predictive Oncology Inc.
Predictive Oncology’s organ-specific in vitro models are designed to better mimic the physiological environment of human tissue The 3D cell culture market is projected to grow by more than 14%...
Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
June 04, 2024 08:41 ET
|
Silo Pharma, Inc.
Clinical roadmap unveiled for novel and proprietary intranasal PTSD treatment SARASOTA, FL, June 04, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a...
Enact to Participate at the 2024 TD Financial Services and Fintech Summit
June 04, 2024 08:40 ET
|
Enact Holdings, Inc.
RALEIGH, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced that the company’s President and Chief Executive Officer, Rohit Gupta, will participate in...
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
June 04, 2024 08:30 ET
|
Surrozen, Inc.
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
June 04, 2024 08:30 ET
|
Nexalin Technology, Inc.
HOUSTON, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap Rodeo...
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
June 04, 2024 08:30 ET
|
Artelo Biosciences
SOLANA BEACH, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...
Eightco’s Forever 8 to attend ITC Malta 2024
June 04, 2024 08:30 ET
|
Eightco Holdings Inc.
Easton, PA, June 04, 2024 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”) today announced that Forever 8 Fund, LLC (“Forever 8”), a subsidiary of Eightco, will...
Skyward Specialty Invests in Media Liability Expansion With the Addition of Three Key Industry Veterans
June 04, 2024 08:30 ET
|
Skyward Specialty Insurance Group, Inc.
HOUSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) ("Skyward Specialty" or "the Company"), a leader in the specialty property and casualty (P&C)...
Phunware Announces At the Market Equity Distribution Program
June 04, 2024 08:30 ET
|
Phunware, Inc.
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (Nasdaq: PHUN, “Phunware”), the leading provider of patented wayfinding and mobile engagement solutions that enables brands to engage,...